Objective To determine risk factors for poor birth outcome and their population attributable fractions. Methods 1688 women who attended for antenatal care were recruited into a prospective study of the effectiveness of syphilis screening and treatment. All women were screened and treated for syphilis and other reproductive tract infections (RTIs) during pregnancy and followed to delivery to measure the incidence of stillbirth, intrauterine growth retardation (IUGR), low birth weight (LBW) and preterm live birth. Findings At delivery, 2.7% of 1536 women experienced a stillbirth, 12% of live births were preterm and 8% were LBW. Stillbirth was independently associated with a past history of stillbirth, short maternal stature and anaemia. LBW was associated with short maternal stature, ethnicity, occupation, gravidity and maternal malaria whereas preterm birth was associated with occupation, age of sexual debut, untreated bacterial vaginosis and maternal malaria. IUGR was associated with gravidity, maternal malaria, short stature, and delivering a female infant. In the women who had been screened and treated for syphilis, in between 20 and 34% of women with each outcome was estimated to be attributable to malaria, and 63% of stillbirths were estimated as being attributable to maternal anaemia. Screening and treatment of RTIs was effective and no association was seen between treated RTIs and adverse pregnancy outcomes. Conclusion Maternal malaria and anaemia continue to be significant causes of adverse pregnancy outcome in sub-Saharan Africa. Providing reproductive health services that include treatment of RTIs and prevention of malaria and maternal anaemia to reduce adverse birth outcomes remains a priority. Voir page 16 le résumé en français. En la página 16 figura un resumen en español.
Introduction
Adverse birth outcomes such as low birth weight (LBW) and prematurity are ass s sociated with increased infant morbidity and mortality. 1 Maternal risk factors that are likely to be particularly important in subsSaharan Africa include reproducs s tive tract infections (RTIs), malaria and human immunodeficiency virus (HIV) infection. [2] [3] [4] [5] The impact of these infecs s tions is likely to be high because they are so prevalent. Up to 50% of stillbirths, for example, have been attributed to uns s treated maternal syphilis. 6, 7 Other RTIs associated with adverse birth outcomes include bacterial vaginosis (BV), gonors s rhoea, and Chlamydia trachomatis and Trichomonas vaginalis infections. [8] [9] [10] [11] [12] A few studies have documented other maternal factors associated with adverse pregnancy outcomes in subs Saharan Africa. [13] [14] [15] [16] [17] [18] [19] [20] However, there are few data on the examination of multiple determinants of birth outcome and the proportion of adverse birth events ats s tributable to these factors from the study region, partly because of a lack of simple, inexpensive diagnostic methods.
Adverse birth outcomes in United Republic of Tanzaniaimpact and prevention of maternal risk factors
We conducted a study to determine the effectiveness of syphilis screening and treatment in preventing adverse pregs s nancy outcomes in women in Mwanza city, northswest United Republic of Tanzania. 21 This study allowed the concomitant measurement of the ims s portance and impact of other maternal factors in this population.
Methods

Study design and participants
The study methods have been described in detail elsewhere. 21 In summary, a prospective cohort of 1688 women ats s tending an antenatal clinic (ANC) was recruited from the main ANC in Mwans s za city from 1997 to 2000 to examine the effectiveness of antenatal screening and treatment of syphilis. Women were A second RTI screen and treatment and an ultrasound examination were offered to women recruited before 32 weeks gestation. Free treatment was ofs s fered to the sexual partners of women with RTIs. Participants were followed to delivery. As soon as possible after admiss s sion, a 10sml venous blood sample and a fingersprick sample for a malaria thick film and haematocrit were collected. A placental blood smear and a 10 mm³ placental biopsy from the maternal plas s cental surface were taken after delivery. Data were collected on birth outcomes and signs of congenital syphilis. Stillbirth was defined as a fetal death after 22 weeks gestation, intrauterine fetal death (IUFD) as fetal death at or before 22 weeks gestation, LBW as birth weight less than 2500 g, prematurity as delivery before 37 weeks gestation and intrauters s ine growth retardation (IUGR) as an LBW infant born at or after 37 weeks gestation. 14, 22, 23 Gestational age was estimated by ultrasound and date of the last menstrual period. To treat potential congenital infections, infants of RPRs positive mothers were given benzathine penicillin G (0.5 mg/kg, intramuscular) as soon as possible after birth.
Laboratory analysis
Serum samples taken at the ANC were tested onssite using a qualitative RPR test. Serum samples from all the women recruited were tested at the reference laboratory by the same RPR test and by the Treponema Palliidum haemagglutis s nation assay (TPHA) and a fluorescent treponemal antibody assay if the results of the RPR test and TPHA were positive and negative, respectively.
Gramsstained vaginal smears were examined for candidiasis and also for BV using the Nugent method. 24 As previously described, trichomoniasis was diagnosed using wet preparations and culture, Neisseria gonorrhoeae by culture and C. trachomatis by an enzyme immus s noassay antigen detection test to allow early treatment of infected women. 21 Firstsvoid urine samples (the first few mls of urine passed when voiding the bladder) were tested by the polymerase chain reaction (PCR) for C. trachomatis and N. gonorrhoeae. Anonymous tests s ing for human immunodeficiency virus (HIV) using screening (Vironostika HIV UnisForm II, Organon Teknika, Boxtel, the Netherlands) and confirmas s tory ELISA (Enzygnost® AntisHIV 1/2 Plus, Behring, Marburg, Germany) was performed on stored maternal serum collected at delivery.
Anaemia at delivery was diagnosed by measuring the percentage packed cell volume (PCV). A PCV of 37% or more was considered normal, 33-36% was defined as mild anaemia, 24-32% as moderate anaemia and below 24% as severe anaemia.
Peripheral and placental blood smears were examined for asexual mas s laria parasites. Placental malaria, diags s nosed by examining placental biopsies, was classified as: uninfected (no parasites or pigment); active (parasites in inters s villous spaces); activeschronic (parasites in maternal erythrocytes and pigment in fibrin or cells within fibrin and/or chorionic villous syncytiotrophoblast or stroma); pastschronic (no parasites and pigment confined to fibrin or cells within fibrin). 25 
Statistical analysis
Data were entered in dBase IV (Ashtons Tate, USA) and analysed in STATA8 (STATA Corporation, Texas, USA). Univariate analysis was performed to compare sociodemographic and maters s nal factors in women who were followed to delivery with those lost to followsup, and between treated RPRspositive and RPRsnegative women. Comparison of proportions was done by the c² test and Fisher's exact test. Means of normally distributed continuous variables were compared using the tstest.
Potential risk factors for stillbirth, LBW, IUGR and preterm birth were examined separately for women followed to delivery. These were not stratified by syphilis serostatus because it had previs s ously been demonstrated that there was no difference in birth outcome between women treated for serological syphilis and seronegative women. 21 To examine potential risk factors for adverse pregs s nancy outcomes, crude and adjusted odds ratios (OR) were obtained using multiple logistic regression. Statistical significance was assessed using the likes s lihood ratio test. Factors significant at P < 0.1 on univariate analyses were ens s tered in a multivariate model. Factors which remained significant (P < 0.10) were included in the final model for each outcome, together with variables of a priori interest (i.e. age, gravidity and HIV status).
The proportion of outcomes in the population attributable to the exposure (population attributable fraction (PAF)) was estimated for malaria, anaemia and HIV at delivery using a modification of the methods outlined by Benichou and Gail. 26 The adjusted PAF = p (R'-1)/R' where p is the prevalence of exposure among cases in the total population and R' is the adjusted relative risk (RR). Bootstrapping techniques were used to calculate the 95% confidence interval for the adjusted PAF. Sampling weights equal to the inverse of the sampling fraction were applied to both the RPRs positive and RPRsnegative women to allow for the sampling strategy.
Results
Cohort recruitment and follow-up
Recruitment and followsup have been described elsewhere. 21 In total, 1688 women were recruited into the cohort: 559 were diagnosed as RPRspositive and 1127 RPRsnegative by reference laboratory testing. Two women had incomplete serology and were excluded from further analysis.
A third trimester screen for RTIs was performed on 1283 (76.1%) women. One hundred and fifty women (8.9%) were lost to followsup before delivery. Women lost presdelivery were younger than those followed up (mean age 22.8 versus 23.8 years, P = 0.01), more likely to be primigravidae (41.3% versus 28.3%, P = 0.001) and not curs s rently married (24.7% versus 14.3%, P = 0.001). Of the 1536 women fols s lowed to delivery, 1205 (78.5%) delivs s ered in hospital and 331 delivered at home or elsewhere. Two women died after giving birth (0.1%), both as a res s sult of postpartum haemorrhage. Birth weight was recorded for 1260 (84.3%) of the 1494 infants born alive.
Baseline sociodemographic characteristics
Further analysis was restricted to the 1536 women who were followed to des s livery. Sociodemographic and maternal factors according to ANC RPR status are shown in Table 1 . The mean age of the women was 23.8 years and most (86%) were currently married. Only 17.5% attended for antenatal care before 20 weeks gestation. The mean gestational age at recruitment was 25.4 weeks (stans s dard deviation (SD) 6.1; range 7.1-42.0 weeks).
There was a high prevalence of RTIs at enrolment, especially BV (29.9%), T. vaginalis (20.5%) and C. albicans (29.6%). PCR testing showed that only 2.2% of the women had gonorrhoea and 7.4% had C. trachomatis.
Prevalence of HIV, malaria and anaemia at delivery
Of 1518 women who had an HIV result at delivery, 177 (11.7%) were HIV posis s tive. Of the 1152 women for whom the results of placental biopsy were available, 451 (39.2%) had evidence of placental malaria (Table 1) . Overall 113/1138 (9.9%) women had maternal malaria (peripheral blood parasitaemia) at the time of delivery. Anaemia was observed in 772/1189 (64.9%) women for whom haematocrit results were available, and 402 (33.8%) had moderate or severe anaemia.
There was a borderline association between HIV and maternal malaria at delivery (14.3% of HIVspositive women had malaria whereas 9.3% were HIVs negative; P = 0.075). An association was noted between parasite density and HIV status: of 126 HIVspositive women for whom a white blood cell count (WBC) had been recorded, 6.4% had a parasite count of > 50/200 WBC at delivery compared to 1.9% of 1002 HIVsnegative women (P = 0.002). The geometric mean parasite density in women with malaria was 12.1/200 WBC in HIVsnegative women and 36.8/200 WBC in HIVs positive women (P = 0.04).
There was no association between placental malaria and HIV status (41.4% of HIVspositive versus 38.8% HIVs negative women; P = 0.56). However, 5.6% of the 126 HIVspositive women had a parasite count in active placental malaria infection of > 50/200 WBC at delivery compared to 1.2% of 1009 HIVsnegative women (P = 0.04) whereas the geometric mean parasite densities were 36.7/200 WBC and 11.4/200 WBC, respectively (P = 0.01).
Risk factors for adverse pregnancy outcomes
In total 230 (18%) of women had an adverse birth outcome. Univariate and multivariate analyses of the association of sociodemographic and biological variables with adverse birth outcomes are shown in Table 2 .
Stillbirth and intrauterine fetal death
Overall, 42/1536 (2.7%) women exs s perienced a stillbirth or IUFD. Two cases of IUFD diagnosed at 19 weeks gestation were combined with stillbirth for this analysis. On univariate analysis, stillbirth was strongly associated with a past history of stillbirth, occupation, being a smoker at recruitment, short stature, and maternal HIV infection and maternal anaemia at delivery.
On multivariate analysis, stillbirth was independently associated with short stature (odds ratio (OR): 2.64), a past history of stillbirth (OR: 7.50) and maternal anaemia (OR: 3.74). Although few women smoked, there was some evidence that those who did were at increased risk of stillbirth (OR: 8.51; 95% confidence interval, 0.9-78.4). There was also a borderline association with being a primigravida and with placental malaria; the highest risk was seen in women with active placental malaria (OR = 7.74) compared with no placental malaria.
Premature birth
Twelve per cent of mothers who had live births gave birth preterm. On univariate analysis, prematurity was associated with younger age (test for trend P = 0.01), occupation, marital status, snuff use, gras s vidity, untreated BV during pregnancy, peripheral maternal malaria, active chronic placental malaria and maternal anaemia at delivery.
Independent risk factors for preterm birth were occupation, sexual debut after age 15 years, untreated BV during pregs s nancy (OR: 2.95) and maternal malaria (OR: 3.19). Women with HIV infection were not at a significantly increased risk of preterm birth (OR: 1.06).
Low birth weight
Overall, 8.2% of live births for whom birth weight was recorded were LBW. On univariate analysis, giving birth to an infant with LBW was associated with younger age, nonsSukuma ethnicity, occupation, never having been mars s ried, short stature, low gravidity, taking metronidazole during pregnancy, uns s treated BV during pregnancy, not having chlamydia during pregnancy, maternal malaria, active chronic placental mas s laria and maternal anaemia. Receiving penicillin at enrolment and testing RPRs positive at enrolment were associated with a lower risk of LBW in the unis s variate analysis. These two variables were strongly associated since RPRspositive women were treated with penicillin.
Independent risk factors for LBW were nonsSukuma ethnicity, occupation (staying at home compared to having employment), short stature (OR: 1.80), being a primigravida (OR: 1.76), not having C. trachomatis infection and mas s ternal malaria (OR: 5.44).
Intrauterine growth retardation
Analyses of IUGR were based on the 1117 women who had fullsterm live births. Of these, 4% were defined as having IUGR which was associated with younger age, nonsSukuma ethnicity, occupation, short stature, low gravidity, female sex of baby, maternal malaria and placental malaria.
Independent risk factors were ocs s cupation, short stature (OR: 1.94), bes s ing a primigravida (OR: 2.14), a female baby (OR: 2.11) and maternal malaria (OR: 2.83).
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Population attributable fractions
The proportions of adverse outcomes attributable to malaria, anaemia and HIV are shown in Table 3 . The press s ence of malaria in pregnancy, either maternal or placental, was associated with statistically significant PAFs of 34% for stillbirth, 20% for prematurity, 28% for LBW and 22% for IUGR. For prematurity, LBW and IUGR, the main associations were with peripheral maters s nal malaria and active chronic placental malaria. In contrast, stillbirth appeared to be attributable to both peripheral and active or chronic placental malaria. A substantial proportion of stillbirths were attributable to maternal anaemia (PAF 63%). The proportion of adverse outcomes attributable to HIV was 5% or less for each outcome.
Discussion
There is a high incidence of adverse birth outcomes in northern United Republic of Tanzania, even in women who receive a package of reproductive health care as part of the antenatal services. Risk factors for adverse birth outcomes are multifactorial and only some of them are preventable or treatable.
Documented risk factors for stills s birth in subsSaharan Africa include low socioeconomic status, nulliparity, mas s ternal syphilis, LBW, mode of delivery, a previous late fetal or early neonatal death and malaria, as well as anaemia and short stature as observed in this study. 7, 13, 27 However, in many African populations without access to screening, maternal syphilis will remain the most important preventable cause of stillbirth. 7 Efforts to screen and treat for this infection must be a priority. 28, 29 Where syphilis screening and treatment is being implemented efs s fectively, as in this study where adverse birth outcomes attributable to syphilis were effectively prevented, anaemia and placental malaria infection remain as other potentially preventable causes of stillbirth.
The risk factors for LBW and IUGR in this study were similar to those described in a previous review which showed that ethnic group, nutrition, low weight prespregnancy, parity, young mas s ternal age, short stature and malaria were important determinants of growth in utero in developing countries. 14 In cons s trast to research findings in Uganda, 30 our study did not find any significant association on multivariate analysis between metronidazole treatment and LBW or preterm birth.
Our study showed a strong assos s ciation between preterm birth and the potentially preventable factors of BV and maternal malaria. Other determinants for prematurity in developing countries are unclear except for prespregnancy weight, maternal age and socioeconomic status. Vitamin A deficiency, which was not measured in our study, may also ins s fluence premature births in subsSaharan Africa. 17 The results of this study highs s light several key points. First, as in other studies in subsSaharan Africa, there was a high prevalence of RTIs in pregnancy. 31, 32 However, apart from untreated BV, these had no significant association with adverse pregnancy outcome. Untreated RTIs have been ass s sociated with all the adverse pregnancy outcomes documented in this study. Treating RTIs in pregnancy with a single dose of ceftriaxone in Nairobi has been shown to increase birth weight and reduce the incidence of postpartum ens s dometritis. 33 A study of mass treatment of RTIs in pregnant women in Uganda reported an increase in birth weight, and a reduction in rates of preterm birth and neonatal death in the intervention arm. 32 In our study, in which treatment of RTIs was provided at several points in pregnancy, RTIs were not independent risk factors for adverse birth outcomes. This emphasizes the importance of inters s vening against RTIs as a routine part of antenatal services because their impact on adverse outcomes can be prevented so effectively. This can be done through simple syndromic management at sevs s eral points during antenatal care, but the use of rapid screening tests for RTIs, once available, may be more effective because they will identify asymptomatic infections. Resscreening women later in pregnancy and efforts to treat contacts should also be intensified.
Second, in a population in which the impact of maternal syphilis in pregs s nancy has been prevented, and in which most pregnant women have been treated for RTIs at the ANC, malaria and anaemia become the most significant preventable causes of adverse birth outs s come. In this study, maternal malaria at delivery was a stronger independent risk factor for prematurity, LBW and IUGR than placental malaria, although active placental malaria infection was associated with stillbirth. In cases of maternal malaria, LBW can result from either IUGR or premature delivery. 34, 35 Infection acquired close to the time of delivery results in preterm birth, whereas antenatal infection acquired earlier ins s creases the risk of IUGR. Maternal HIV infection
Note: bold type indicates a statistically significant result. a Calculated by bootstrapping the formula p(OR-1)/OR where p is the proportion of cases exposed in the target population, and the odds ratio (OR) is the adjusted OR in Table 3 . Estimates are based on 1000 bootstrap samples. b Prevalence of exposure in the target population, adjusted for the weighted sample of rapid plasma reagin assay (RPR)-positive and negative women selected into the study. c Any pregnancy ending in a stillbirth or delivery of a preterm or a low-birth-weight infant or an infant with intrauterine growth retardation. d Evidence of placental and/or peripheral maternal malaria infection.
In contrast to other studies in subs Saharan Africa, this study did not show any independent risk of adverse pregs s nancy outcome associated with maternal HIV infection. 36 However, an assos s ciation between HIV status and both peripheral and placental malaria and higher parasite densities in HIVsinfected individuals was seen in this study as well as in several previous studies. [37] [38] [39] Paritys specific immunity appears to be reduced in HIVspositive women; women of all parities have a higher relative risk for malaria if they are HIVspositive. 27, 37, 39, 40 This in turn may lead to an even higher rate of adverse pregnancy outcomes, als s though we did not observe this, with the exception of a univariate effect of HIV on stillbirth. Any effect on pregnancy outcome may be partially mediated through the effect of HIV infection on malaria and/or anaemia. Malaria pros s phylaxis may not be effective in this situation because placental parasitaemia was more common in HIVspositive than in HIVsnegative pregnant women treated with sulfadoxine-pyrimethamine in Kenya. 38 Similar findings have been reported from Malawi. 40 In developing countries, maternal anaemia is usually the result of iron deficiency and/or malaria. Hookworm infection and poor diet are believed to be important causes of iron deficiency. 41, 42 Iron supplementation during pregnancy is therefore generally recommended and has been shown to increase the haemos s globin level and PCV in the mother's blood postsdelivery and to increase the mean birth weight of infants. 43 Maternal anaemia was not prevented in our study and this may relate to poor adherence to treatment with iron supplements or failure to control malaria adequately because of chloroquine resistance.
Both malaria and HIV can affect pregnancy outcomes indirectly bes s cause they are risk factors for maternal anaemia. 2, 42, 44, 45 Malaria prophylaxis in pregnancy can reduce the incidence of thirdstrimester anaemia 38 and is geners s ally recommended as a part of prenatal care in malariasendemic areas. 46 This has been effective in reducing the incidence of LBW infants, especially those born to primigravidae, and in reducing maternal anaemia. [47] [48] [49] Trials of sulphadoxinepyrimethamine have reduced placental malaria and may explain how chemos s prophylaxis increases birth weight 38, 50 Malaria prophylaxis has had little effect on the rate of other birth outcomes such as stillbirths or neonatal deaths. 48 In our study, chloroquine was the recoms s mended chemoprophylactic but had limited effectiveness in preventing infecs s tion because chloroquine resistance is common. 34 Efforts are now being made in many parts of subsSaharan Africa to change to more effective regimens. 49 The potential impact of an effective intervens s tion will be significant at the population level because more than one third of LBW and stillbirth cases and nearly a quarter of IUGR cases were attributs s able to malaria. Given the relationship between malaria and HIV in pregnant women infected with both, it will be important to document the effectives s ness of antiretroviral therapy for HIV on pregnancy outcomes and on the prevalence and severity of malaria in pregnancy in subsSaharan 
Resumen
Desenlaces adversos del parto en la República Unida de Tanzanía: impacto y prevención de los factores de riesgo maternos Objetivo Identificar los factores de riesgo de desenlace adverso del parto y sus fracciones poblacionales atribuibles. Métodos En un estudio prospectivo sobre la eficacia de la detección y tratamiento de la sífilis se incluyeron 1688 mujeres que esperaban recibir atención prenatal. Todas ellas fueron sometidas a pruebas de detección y tratamiento de la sífilis y de otras infecciones del aparato reproductor durante el embarazo, y fueron observadas hasta el parto para determinar la incidencia de muerte fetal, retraso del crecimiento intrauterino, bajo peso al nacer y parto antes del término. Resultados Entre las 1536 mujeres observadas hasta el parto hubo un 2,7% de muertes fetales, un 12% de nacidos vivos antes del término y un 8% de recién nacidos con bajo peso al nacer. La muerte fetal se asoció de forma independiente a los antecedentes de muerte fetal y a la anemia y la baja estatura de la madre. El bajo peso al nacer se asoció a la baja estatura de la madre, su etnia y ocupación, el número de embarazos anteriores y los antecedentes de paludismo, mientras que el parto antes del término se asoció con la ocupación, la edad de inicio de las relaciones sexuales, la vaginosis bacteriana no tratada y los antecedentes de paludismo. El retraso del crecimiento intrauterino se asoció con el número de embarazos anteriores, el paludismo, la baja estatura de la madre y el sexo femenino del recién nacido. En estas mujeres sometidas a pruebas de detección y tratamiento de la sífilis, entre un 20 y un 34% de cada uno de los desenlaces adversos fueron atribuibles al paludismo, mientras que el 63% de las muertes fetales fueron atribuibles a la anemia materna. La detección y tratamiento de las infecciones del aparato reproductor fue eficaz y no se observó ninguna asociación entre las infecciones tratadas y los desenlaces adversos del embarazo. Conclusión El paludismo y la anemia materna siguen siendo causas importantes de desenlace adverso del embarazo en el África subsahariana. La prestación de servicios de salud reproductiva que incluyan el tratamiento de las infecciones del aparato reproductor y la prevención de la malaria y la anemia materna siguen siendo prioritarias para reducir los desenlaces adversos del embarazo.
